On

OncoImmunology

OncoImmunology is a dynamic, high-profile, open access journal covering tumor immunology and immunotherapy, including basic and translational studies in solid and hematological malignancies, immune responses against cancer, cancer immunoediting and immune evasion, modern immunotherapies, and immunological effects of conventional anticancer therapies.

Looking to publish in OncoImmunology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Existing customer login
Subject Immunology, Oncology
Impact Factor 6.3
Quartile Q1
Open Access Type Open
ISSN 2162-402X
eISSN 2162-402X
Invitation Only Yes
Cost Range Article Publishing Charge (APC) required for open access publication; institutional agreements, discounts, and waivers may reduce or cover the APC

Submission Instructions

OncoImmunology is an invitation-only journal. Submissions are accepted by invitation from the editorial board only. The following article types are accepted:

Research Article

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required. Abstract must be 250 words. Abstract must be unstructured.
Manuscript Manuscript must be no more than 5,000 words. Manuscript must be ordered as title page, abstract, keywords, introduction, materials and methods, results, discussion, acknowledgments, declaration of interest statement, references, appendices as appropriate, tables with captions on individual pages, figures, and figure captions as a list. Manuscript must include keywords and a declaration of interest statement.
References References must not exceed 80. References may be in any consistent scholarly citation style or format. References must include complete bibliographic details and every entry must have a corresponding in-text citation.
Figures & Tables Figures and tables are limited to a combined maximum of 8, with additional figures or tables permitted as supplementary material. Figures and tables may be placed within the text or submitted as separate documents.
Reformat to OncoImmunology using Livewrite Premium

Review Articles

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required. Abstract must be 250 words. Abstract must be unstructured.
Manuscript Manuscript must be no more than 5,000 words. Manuscript must be ordered as title page, abstract, keywords, introduction, materials and methods, results, discussion, acknowledgments, declaration of interest statement, references, appendices as appropriate, tables with captions on individual pages, figures, and figure captions as a list. Manuscript must include keywords and a declaration of interest statement.
References References may be in any style or format if a consistent scholarly citation format is used. References must include the author name or names, journal or book title, article or chapter title, year of publication, volume and issue where appropriate, and page numbers, and every bibliographic entry must have a corresponding in-text citation.
Figures & Tables A maximum of 6 figures and tables combined is permitted, with additional figures or tables allowed in supplementary material. Tables with captions must appear on individual pages, followed by figures and then figure captions as a list.
Reformat to OncoImmunology using Livewrite Premium

Brief Reports

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required. Abstract must be 200 words. Abstract must be unstructured.
Manuscript Manuscript must be ordered as title page, abstract, keywords, prior presentations of the work, main text with Introduction, Materials and Methods, Results, and Discussion, acknowledgments, declaration of interest statement, references, appendices as appropriate, tables with captions on individual pages, figures, and figure captions as a list. Manuscript must include 5 to 10 keywords and a declaration of interest statement.
References References must not exceed 30. References may be in any consistent scholarly citation style or format. References must include author name or names, journal or book title, article or chapter title, year of publication, volume and issue where appropriate, and page numbers, and every bibliographic entry must have a corresponding in-text citation.
Figures & Tables There must be no more than 3 display items in total, with additional figures or tables allowed as supplementary material. Figures and tables may be placed within the text or submitted as separate documents.
Reformat to OncoImmunology using Livewrite Premium

Recent Publications

Preclinical evaluation of homodimeric FAPI target modules for UniCAR-mediated targeting of FAP-expressing tumor and stromal cells

Hugo Boutier, Simona Mattiussi, Liliana R. Loureiro, Nicole Berndt, Antonia Stammberger, Nathalia Jones-Cifuentes, Lydia Hoffmann, Emile Verhulst, Marc Schmitz, Ingrid De Meester, Umberto M. Battisti, Claudia Arndt, Anja Feldmann, Frank Roesch, Matthias M. Herth, Michael Bachmann

10.1080/2162402x.2026.2717836
View Publication

Myeloid-derived MIF is a central regulator of MDSC-driven T-cell dysfunction in head and neck squamous cell carcinoma

Suvekshya Shrestha, Felipe Lamenza, Natalie Kazmierowicz, Kishan Kumar Nyati, Sushmitha Jagadeesha, Ravi Ramalingam, Reegan Kehres, Puja Upadhaya, Arham Siddiqui, Shaheer Masood, Massar Yade, Sonali Dasari, Steve Oghumu

10.1080/2162402x.2026.2719293
View Publication

HLA-G functions as a tumor-intrinsic driver of growth and survival in renal cell carcinoma

Ashwin Ajith, Aparna Geetha Jayaprasad, Useong Chang, Arsha Sreekumar, Mia Lin, Valia Bravo-Egana, Laura L. Mulloy, Daniel David Horuzsko, Edgardo D. Carosella, Anatolij Horuzsko

10.1080/2162402x.2026.2717680
View Publication

Histidine-improved cancer immunosurveillance

Marine Fidelle, Ella Reich, Laurence Zitvogel, Guido Kroemer

10.1080/2162402x.2026.2713805
View Publication

Bi-directional support of T lymphoma and a lymphoma-associated monocyte population involving Notch signaling in mice

Sigrid Dubois, Yetzali Claudio-Medina, Jennifer L. Marte, James L. Gulley, Juergen R. Mueller

10.1080/2162402x.2026.2713290
View Publication

Frequently asked questions

How long does it take to publish?

3 days avg. from submission to first decision; 47 days avg. from submission to first post-review decision; 15 days avg. from acceptance to online publication.

Reformat to OncoImmunology using Livewrite Premium

Is a cover letter required?

A cover letter is supported and guidance is provided, but it is not stated as required.

Reformat to OncoImmunology using Livewrite Premium

What are the publication costs?

Article Publishing Charge (APC) may be required for publication. Institutional agreements, discounts, and waivers may reduce or cover the APC.

Reformat to OncoImmunology using Livewrite Premium

Research Topics

Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses Immune Cell Function and Interaction CAR-T cell therapy research Immune cells in cancer T-cell and B-cell Immunology Virus-based gene therapy research Monoclonal and Polyclonal Antibodies Research Immune Response and Inflammation Phagocytosis and Immune Regulation Cancer Cells and Metastasis Cancer Research and Treatments RNA Interference and Gene Delivery vaccines and immunoinformatics approaches Chemokine receptors and signaling interferon and immune responses Lymphoma Diagnosis and Treatment Ferroptosis and cancer prognosis Cancer, Stress, Anesthesia, and Immune Response Cytokine Signaling Pathways and Interactions Pancreatic and Hepatic Oncology Research Glioma Diagnosis and Treatment Cancer, Hypoxia, and Metabolism Adenosine and Purinergic Signaling Peptidase Inhibition and Analysis

Related Journals

BT
Brain Tumor Pathology Springer Science+Business Media
NB
npj Breast Cancer NATURE PORTFOLIO
RI
Radiology Imaging Cancer Radiological Society of North America
C&
Cancer & Metabolism BioMed Central
JO
Journal of the National Cancer Center Elsevier BV
AR
Anticancer Research International Institute of Anticancer Research (IIAR) Conferences 1997. Athens, Greece. Abstracts